Your browser does not support Javascript
email@mymsaa.org
Multiple Sclerosis Association of America Logo
Link to FaceBook Link to Twitter Link to YouTube Link to Pinterest
Register Why Register Contact MSAA Site Preferences Print Page Home
Improving Lives Today!
Donate Button
The Motivator iconMSAA's MAGAZINE
The Motivator
Booklets and Brochures iconBooklets & Brochures
MS Research Update 2014
MS Research Update 2013
About MS
Medicare Planning
and Multiple Sclerosis
The Affordable Care Act
and Multiple Sclerosis
Aquatic Exercise and Multiple Sclerosis:
A Guide for Patients
How to S.E.A.R.C.H.™ for the Right
MS Therapy for You!
Understanding and Treating
MS Relapses
Solutions for Wellness: A Guide to
MSAA's Programs and Services -
Second Edition
The Multiple Sclerosis Association
of America Programs & Services
Guide in Spanish
Mommy's Story
Daddy's Story
Understanding and Treating
Depression in Multiple Sclerosis
MSAA Monograph: Thinking about
Complementary and Alternative
Medicine?
MSAA Monograph: The Confusing
World of Clinical Trials
Multiple Sclerosis and Cooling
(3rd edition)
Primary Progressive Multiple
Sclerosis: What You Need to Know
Order Publications iconOrder Publications
Individual Order
Group Orders



Home > MSAA Publications > The Motivator > The Motivator: Winter/Spring 2009 > Cover Story - Symptom Management Update > SECTION 9: ANXIETY
Share this Page:
submit to reddit

< SECTION 8: DEPRESSION - Home - SECTION 10: SLEEP DISTURBANCES >

SECTION 9: ANXIETY

Anxiety is common in MS, and may be related to depression. In many cases, medications used to treat depression will also alleviate symptoms of anxiety. A recent study at the University of Washington indicated that about one-quarter of all people with MS experience anxiety, and most of them also experience depression.

NON-PHARMACOLOGIC MANAGEMENT

As with depression, and because of the wide range of issues that can contribute to depression, the most effective results are usually obtained with a combination of "talk therapy" (counseling) and pharmacologic agents.

A number of relaxation and therapeutic therapies can also be very helpful in reducing anxiety. Among others, these include exercise, biofeedback, guided imagery, self hypnosis, yoga, tai chi, and massage.

PHARMACOLOGIC MANAGEMENT

Benzodiazepines
including Valium® (diazepam), Serax® (oxazepam), Ativan® (lorazepam), Klonopin® (clonazepam), and Xanax® (alprazolam)

Valium was the first benzodiazepine approved by the FDA for the treatment of anxiety, and most of the agents used to manage this symptom in MS are derivatives of this drug.

Doses vary depending on the specific molecular structure of the diazepam derivatives. All are useful in treating anxiety and panic disorders, as well as the anxiety that is directly related to depression; these conditions are normally treated as a single entity. These drugs must be carefully monitored as they may cause dependence.

Side effects include confusion, depression, drowsiness, insomnia, light-headedness or dizziness, headache, urinary difficulties, and tremor. Habituation - a decrease in response after repeated use - is a concern.

< SECTION 8: DEPRESSION - Home - SECTION 10: SLEEP DISTURBANCES >

Last Updated on Friday, 10 May 2013 10:25